RhumbLine Advisers’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
108,414
+19,526
| +22% | +$182K | ﹤0.01% | 2246 |
|
|
2025
Q1 | $598K | Buy |
88,888
+20,721
| +30% | +$139K | ﹤0.01% | 2464 |
|
|
2024
Q4 | $724K | Sell |
68,167
-852
| -1% | -$9.05K | ﹤0.01% | 2428 |
|
|
2024
Q3 | $1.01M | Buy |
69,019
+1,835
| +3% | +$26.8K | ﹤0.01% | 2260 |
|
|
2024
Q2 | $813K | Buy |
+67,184
| New | +$813K | ﹤0.01% | 2359 |
|